Lipocalin 2: a potential therapeutic target for breast cancer metastasis Chenxia Hu,1 Ke Yang,1 Mengjie Li,1 Weiping Huang,2 Fengxue Zhang,2 Hongqi Wang2 1School of Pharmaceutical Science, Guangzhou
inputs to improve the article. Author Contributions Conceptualization: Jie Chen. Funding acquisition: Jie Chen. Investigation: Jida Xing, Shrishti Singh, Yupeng Zhao, Yan Duan, Huining Guo, Chenxia Hu
Terminal liver disease is a major cause of death globally. The only ultimate therapeutic approach is orthotopic liver transplant. Because of the innate defects of organ transplantation, stem cell-based therapy has emerged as an effective alternative, based on the capacity of stem cells for multilineage differentiation and their homing to injured sites. However, the disease...
, Zhejiang ZJ 571, China Received 7 May 2015; Revised 17 June 2015; Accepted 13 July 2015 Academic Editor: Benedetta Bussolati Copyright © 2015 Chenxia Hu and Lanjuan Li. This is an open access article
cells for liver regeneration Chenxia Hu 0 Lanjuan Li 0 0 Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious ... stem cellderived hepatocytes; PH, partial hepatectomy; SHs, small hepatocyte-like progenitor cells; TFs, transcription factors. COMPLIANCE WITH ETHICS GUIDELINES Chenxia Hu and Lanjuan Li declare that